<DOC>
	<DOC>NCT00943683</DOC>
	<brief_summary>A study of Montelukast compared to placebo in asthmatic children aged 6-24 months.</brief_summary>
	<brief_title>Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient is in good, stable health Patient has been fed solid foods for at least 1 month Patients had at least 3 episodes of asthma or asthmalike symptoms, all occurring after 8 weeks of age; at least one within 6 months of the Prestudy Visit Patients had to be in need of a controller therapy according to criteria established in the Global Initiative for Asthma (GINA) guidelines Patient was hospitalized at the start of the study or required a visit to the emergency room due to asthma with in past 2 weeks</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>